Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Contraceptive Hormones and Women With Cystic Fibrosis
NCT02144246Phase 1Terminated
- Sponsor
- University of Pennsylvania
- Start
- May 2014
- Primary completion
- Jul 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of ethinyl estradiol in cystic fibrosis (CF) (2 arms), sponsored by University of Pennsylvania. Primary endpoints: Satisfaction with contraception at 18 months and Exacerbation rate at 18 months. Started May 2014; status: terminated.
02
Drugs
ethinyl estradiol
03
Conditions
cystic fibrosis (CF)
Beyond the preview
Go deeper on NCT02144246.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02144246.